LIMN
Price
$3.47
Change
-$0.16 (-4.41%)
Updated
Sep 11 closing price
Capitalization
4.66M
Intraday BUY SELL Signals
UPB
Price
$5.73
Change
-$0.02 (-0.35%)
Updated
Sep 11 closing price
Capitalization
313.29M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LIMN vs UPB

LIMN vs UPB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LIMN vs. UPB commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIMN is a Hold and UPB is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UPB($313M) has a higher market cap than LIMN($4.66M). UPB YTD gains are higher at: -78.895 vs. LIMN (-88.623). LIMN has higher annual earnings (EBITDA): -12.45M vs. UPB (-169.78M). UPB has more cash in the bank: 261M vs. LIMN (3.02M). UPB has less debt than LIMN: UPB (954K) vs LIMN (1.44M). UPB has higher revenues than LIMN: UPB (3.16M) vs LIMN (0).
LIMNUPBLIMN / UPB
Capitalization4.66M313M1%
EBITDA-12.45M-169.78M7%
Gain YTD-88.623-78.895112%
P/E RatioN/AN/A-
Revenue03.16M-
Total Cash3.02M261M1%
Total Debt1.44M954K151%
TECHNICAL ANALYSIS
Technical Analysis
LIMNUPB
RSI
ODDS (%)
Bearish Trend 2 days ago
21%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
25%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
32%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
44%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
26%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
82%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (LIMN: $3.47 vs. UPB: $5.73)
Brand notoriety: LIMN and UPB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIMN: 13% vs. UPB: 96%
Market capitalization -- LIMN: $4.66M vs. UPB: $313.29M
LIMN [@Biotechnology] is valued at $4.66M. UPB’s [@Biotechnology] market capitalization is $313.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIMN’s FA Score shows that 0 FA rating(s) are green while UPB’s FA Score has 1 green FA rating(s).

  • LIMN’s FA Score: 0 green, 5 red.
  • UPB’s FA Score: 1 green, 4 red.
According to our system of comparison, UPB is a better buy in the long-term than LIMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LIMN’s TA Score shows that 1 TA indicator(s) are bullish while UPB’s TA Score has 2 bullish TA indicator(s).

  • LIMN’s TA Score: 1 bullish, 8 bearish.
  • UPB’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, both LIMN and UPB are a bad buy in the short-term.

Price Growth

LIMN (@Biotechnology) experienced а -5.96% price change this week, while UPB (@Biotechnology) price change was -4.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

UPB is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
LIMN
Daily Signal:
Gain/Loss:
UPB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFUSX50.870.44
+0.87%
DFA US Large Company I
NCLEX24.82N/A
N/A
Nicholas Limited Edition I
NMFIX14.31N/A
N/A
Northern Multi-Mgr Glbl Listed Infra
ENPIX68.77N/A
N/A
ProFunds UltraSector Energy Investor
TSMEX18.61N/A
N/A
Nuveen Quant Small/Mid Cap Eq A

LIMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIMN has been loosely correlated with FTH. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if LIMN jumps, then FTH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIMN
1D Price
Change %
LIMN100%
-4.41%
FTH - LIMN
35%
Loosely correlated
-4.00%
UPB - LIMN
35%
Loosely correlated
-0.35%
IMMP - LIMN
34%
Loosely correlated
+14.83%
RNA - LIMN
32%
Poorly correlated
+0.10%
ALDX - LIMN
31%
Poorly correlated
-8.22%
More

UPB and

Correlation & Price change

A.I.dvisor indicates that over the last year, UPB has been loosely correlated with IRON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if UPB jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UPB
1D Price
Change %
UPB100%
-0.35%
IRON - UPB
36%
Loosely correlated
-5.50%
LIMN - UPB
35%
Loosely correlated
-4.41%
IMNM - UPB
35%
Loosely correlated
-1.20%
FATE - UPB
33%
Loosely correlated
-0.86%
ARVN - UPB
33%
Loosely correlated
-2.99%
More